Annual FCF:
-$363.61M+$7.32M(+1.97%)Summary
- As of today, DNLI annual free cash flow is -$363.61 million, with the most recent change of +$7.32 million (+1.97%) on December 31, 2024.
- During the last 3 years, DNLI annual free cash flow has fallen by -$143.72 million (-65.36%).
- DNLI annual free cash flow is now -188.03% below its all-time high of $413.06 million, reached on December 31, 2020.
Performance
DNLI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$79.58M+$56.97M(+41.72%)Summary
- As of today, DNLI quarterly free cash flow is -$79.58 million, with the most recent change of +$56.97 million (+41.72%) on June 30, 2025.
- Over the past year, DNLI quarterly free cash flow has increased by +$16.43 million (+17.11%).
- DNLI quarterly free cash flow is now -115.52% below its all-time high of $512.72 million, reached on December 31, 2020.
Performance
DNLI Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$367.95M+$16.43M(+4.27%)Summary
- As of today, DNLI TTM free cash flow is -$367.95 million, with the most recent change of +$16.43 million (+4.27%) on June 30, 2025.
- Over the past year, DNLI TTM free cash flow has increased by +$34.15 million (+8.49%).
- DNLI TTM free cash flow is now -188.58% below its all-time high of $415.39 million, reached on March 31, 2021.
Performance
DNLI TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
DNLI Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +2.0% | +17.1% | +8.5% |
| 3Y3 Years | -65.4% | -73.8% | -57.4% |
| 5Y5 Years | -114.5% | -82.2% | -145.2% |
DNLI Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -65.4% | +2.0% | -29.2% | +41.7% | -48.4% | +13.4% |
| 5Y | 5-Year | -188.0% | +2.0% | -115.5% | +41.7% | -188.6% | +13.4% |
| All-Time | All-Time | -188.0% | +2.0% | -115.5% | +41.7% | -188.6% | +13.4% |
DNLI Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$79.58M(+41.7%) | -$367.95M(+4.3%) |
| Mar 2025 | - | -$136.55M(-53.8%) | -$384.38M(-5.7%) |
| Dec 2024 | -$363.61M(+2.0%) | -$88.81M(-40.9%) | -$363.61M(+3.2%) |
| Sep 2024 | - | -$63.02M(+34.4%) | -$375.69M(+6.6%) |
| Jun 2024 | - | -$96.01M(+17.1%) | -$402.10M(+5.4%) |
| Mar 2024 | - | -$115.77M(-14.7%) | -$425.11M(-14.6%) |
| Dec 2023 | -$370.93M(-41.3%) | -$100.89M(-12.8%) | -$370.93M(-6.7%) |
| Sep 2023 | - | -$89.43M(+24.9%) | -$347.55M(-8.2%) |
| Jun 2023 | - | -$119.02M(-93.3%) | -$321.21M(-29.5%) |
| Mar 2023 | - | -$61.59M(+20.5%) | -$247.99M(+5.5%) |
| Dec 2022 | -$262.55M(-19.4%) | -$77.51M(-22.8%) | -$262.55M(-3.5%) |
| Sep 2022 | - | -$63.10M(-37.8%) | -$253.58M(-8.5%) |
| Jun 2022 | - | -$45.79M(+39.9%) | -$233.80M(+3.8%) |
| Mar 2022 | - | -$76.15M(-11.1%) | -$243.00M(-10.5%) |
| Dec 2021 | -$219.89M | -$68.55M(-58.3%) | -$219.89M(-160.8%) |
| Sep 2021 | - | -$43.31M(+21.2%) | $361.38M(-10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$54.99M(-3.7%) | $404.07M(-2.7%) |
| Mar 2021 | - | -$53.04M(-110.3%) | $415.39M(+0.6%) |
| Dec 2020 | $413.06M(+343.7%) | $512.72M(>+9900.0%) | $413.06M(+375.2%) |
| Sep 2020 | - | -$620.00K(+98.6%) | -$150.08M(+17.9%) |
| Jun 2020 | - | -$43.67M(+21.1%) | -$182.74M(+5.1%) |
| Mar 2020 | - | -$55.37M(-9.8%) | -$192.51M(-13.6%) |
| Dec 2019 | -$169.50M(-462.8%) | -$50.42M(-51.5%) | -$169.50M(-520.2%) |
| Sep 2019 | - | -$33.28M(+37.7%) | -$27.33M(+8.0%) |
| Jun 2019 | - | -$53.45M(-65.2%) | -$29.72M(-59.2%) |
| Mar 2019 | - | -$32.35M(-135.3%) | -$18.67M(-140.0%) |
| Dec 2018 | $46.72M(+158.8%) | $91.75M(+357.2%) | $46.72M(+172.5%) |
| Sep 2018 | - | -$35.67M(+15.9%) | -$64.43M(-124.0%) |
| Jun 2018 | - | -$42.40M(-228.3%) | -$28.76M(-311.0%) |
| Mar 2018 | - | $33.04M(+270.2%) | $13.63M(+170.2%) |
| Dec 2017 | -$79.51M(-1.9%) | -$19.41M(+6.2%) | -$19.41M(+6.2%) |
| Dec 2016 | -$78.04M(-330.8%) | -$20.68M | -$20.68M |
| Dec 2015 | -$18.11M | - | - |
FAQ
- What is Denali Therapeutics Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual free cash flow year-on-year change?
- What is Denali Therapeutics Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly free cash flow year-on-year change?
- What is Denali Therapeutics Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. TTM free cash flow year-on-year change?
What is Denali Therapeutics Inc. annual free cash flow?
The current annual free cash flow of DNLI is -$363.61M
What is the all-time high annual free cash flow for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual free cash flow is $413.06M
What is Denali Therapeutics Inc. annual free cash flow year-on-year change?
Over the past year, DNLI annual free cash flow has changed by +$7.32M (+1.97%)
What is Denali Therapeutics Inc. quarterly free cash flow?
The current quarterly free cash flow of DNLI is -$79.58M
What is the all-time high quarterly free cash flow for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly free cash flow is $512.72M
What is Denali Therapeutics Inc. quarterly free cash flow year-on-year change?
Over the past year, DNLI quarterly free cash flow has changed by +$16.43M (+17.11%)
What is Denali Therapeutics Inc. TTM free cash flow?
The current TTM free cash flow of DNLI is -$367.95M
What is the all-time high TTM free cash flow for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high TTM free cash flow is $415.39M
What is Denali Therapeutics Inc. TTM free cash flow year-on-year change?
Over the past year, DNLI TTM free cash flow has changed by +$34.15M (+8.49%)